Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.

Noor, Nudrat; Ebekozien, Osagie; Levin, Laura; Stone, Sheri; Sparling, David P; Rapaport, Robert; Maahs, David M

Noor, Nudrat; Ebekozien, Osagie; Levin, Laura; Stone, Sheri; Sparling, David P; Rapaport, Robert; Maahs, David M.

Noor N; Quality Improvement and Population Health, T1D Exchange, Boston, MA nnoor@t1dexchange.org.
Ebekozien O; Quality Improvement and Population Health, T1D Exchange, Boston, MA.
Levin L; University of Mississippi Medical Center, Jackson, MS.
Stone S; Lurie Children Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL.
Sparling DP; State University of New York Upstate Medical University, Syracuse, NY.
Rapaport R; Harold Hamm Diabetes Center, University of Oklahoma College of Medicine, Oklahoma City, OK.
Maahs DM; Icahn School of Medicine at Mount Sinai, New York, NY.

Diabetes Care ; 44(8): e160-e162, 2021 08.

Article in English | MEDLINE | ID: covidwho-1357491

Subject(s)

COVID-19; Diabetes Mellitus, Type 1; Humans; Registries; SARS-CoV-2; Technology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Limits: Humans Language: English Journal: Diabetes Care Year: 2021 Document Type: Article Affiliation country: Dc21-0074

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google